Justin McLawhorn, MD
MOHS-Micrographic Surgery · Little Rock, ARNPI 1316474471
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,115 of the $12,735 with a category attached, or 71.6%. Pfizer accounts for 75.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $9,569 and has fallen 97.1% since, to $280 in 2025.
Across 147 payments — averaging $86.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$10K
- Novartis$493
- Regeneron Healthcare Solutions, Inc.$381
- AbbVie$374
- Lilly USA, LLC$353
- Sun Pharmaceutical Industries Inc.$319
- plus $1K from 11 others
What the payments were for
- Travel & lodging$9,11572%
- Food & beverage$3,42527%
- Education$1952%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 9 | $9,607 |
| Novartis | 27 | $493 |
| Regeneron Healthcare Solutions, Inc. | 16 | $381 |
| AbbVie | 25 | $374 |
| Lilly USA, LLC | 17 | $353 |
| Sun Pharmaceutical Industries Inc. | 12 | $319 |
| Incyte Corporation | 8 | $225 |
| LEO Pharma Inc. | 7 | $166 |
| UCB, Inc. | 8 | $160 |
| Kyowa Kirin, Inc. | 1 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $125 |
| Dermira, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 6 | $114 |
| Amgen | 3 | $58 |
| Johnson & Johnson | 3 | $52 |
| Boehringer Ingelheim | 2 | $37 |
| Organon | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 47 | $2,795 |
| Ketoconazole | 92 | $1,915 |
| Tacrolimus | 16 | $1,790 |
| Mupirocin | 64 | $539 |
| Doxycycline Monohydrate | 50 | $538 |
| Triamcinolone Acetonide | 65 | $504 |
| Clindamycin Phosphate | 11 | $440 |
| CiclopiroxCiclopirox Olamine | 12 | $251 |
| Hydrocortisone | 47 | $242 |
| Hydroxychloroquine Sulfate | 12 | $228 |
| Cephalexin | 46 | $167 |
| Doxycycline Hyclate | 15 | $152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $74 |
| Fluconazole | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Little Rock
- Scott DinehartLittle Rock$268K
- Michael OsleberLittle Rock$2K
- Joseph PurnellLittle Rock$1K
- Randall BreauLittle Rock$1K
- Colton NielsonJonesboro$13K
- Kattie AllenBentonville$6K
- Courtney BookBentonville$5K
- Mark NaylorFayetteville$3K
- Stephen MasonHot Springs$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.